MARIA MIKULSKI: Open Payments
NPI 1306056932 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$187 in 7 payments from 3 companies in 2025. Trend: 2023 $433 · 2024 $275 · 2025 $187
Food & beverage: $187
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $130 |
| Iovance Biotherapeutics, Inc. | 1 | $40 |
| Deciphera Pharmaceuticals Inc. | 1 | $17 |
Products named: SCEMBLIX, Fabhalta, Amtagvi, QINLOCK.
Industry payments across MD — which companies pay providers there.
